Tracon Pharmaceuticals, Inc.
TCON
Revenue
55.00k
▼-45.00k▼-45.00%
3 Months ChangeAssets
7.40M
▼-1.96M▼-20.90%
3 Months ChangeLiabilities
10.49M
▼-628.00k▼-5.65%
3 Months ChangeFree Cash Flow
-6.75M
▼-1.88M▼-38.72%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-11
Form 8-K
ID: 0000950170-24-114315
2024-08-13
Form 10-Q
ID: 0000950170-24-096403
2024-07-30
Form 8-K
ID: 0000950170-24-087947
2024-07-16
Form 8-K
ID: 0000950170-24-083974
2024-07-01
Form 8-K
ID: 0000950170-24-079290
2024-06-21
Form 8-K
ID: 0000950170-24-076330
2024-06-12
Form 8-K
ID: 0000950170-24-072265
2024-05-14
Form 10-Q
ID: 0000950170-24-059752
2024-05-14
Form 8-K
ID: 0000950170-24-059509
2024-05-13
Form 8-K
ID: 0000950170-24-058206